Clinical trial
A Phase 2 Study to Evaluate Immune Responses of FluMist®
NCT00461981 · MedImmune LLC, Industry · Completed
Key facts
| NCT number | NCT00461981 |
|---|---|
| Title | A Phase 2 Study to Evaluate Immune Responses of FluMist® |
| Official title | A Phase 2, Prospective, Randomized, Open-Label Study to Evaluate the Immune Responses of FluMist® Compared With Trivalent Inactivated Vaccine (TIV) in Children 12 to <36 Months of Age |
| Lead sponsor | MedImmune LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Influenza Vaccine |
| Intervention type | Biological |
| Interventions | TIV, Trivalent Inactivated Influenza Virus Vaccine, FluMist, Influenza Virus Vaccine Live |
| Enrollment | 101 |
| Start date | May 1, 2007 |
| Primary completion | Dec 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | Apr 18, 2007 |
| Last update posted | Oct 6, 2021 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: